Fresenius Medical Care AG

In News

Fresenius Medical Care delivers strong organic revenue growth and double-digit operating income growth in the second quarter of 2025 - Fresenius Medical Care

Fresenius Medical Care - Aug 05, 2025

Fresenius Medical Care AG : Release of a capital market information - TradingView — Track All Markets

TradingView — Track All Markets - Jan 12, 2026

At €40.17, Is It Time To Put Fresenius Medical Care AG (ETR:FME) On Your Watch List? - Yahoo Finance

Yahoo Finance - Jan 05, 2026

Fresenius Medical Care Accelerates Second Tranche of €1 Billion Share Buyback - TipRanks

TipRanks - Jan 12, 2026

Fresenius Medical Care AG (FMS) Stock Analysis: Discovering a Potential 22.72% Upside in Healthcare - DirectorsTalk Interviews

DirectorsTalk Interviews - Jan 12, 2026

Fresenius Medical Care further accelerates organic revenue development and achieves an inflection in earnings growth, delivering 28% operating income growth in the third quarter of 2025 - PR Newswire

PR Newswire - Nov 04, 2025

Fresenius Medical Care Continues EUR 1 Bln Share Buyback With Second Tranche - Nasdaq

Nasdaq - Jan 09, 2026

Dialysis giant to spend EUR 415M buying back its own shares faster - Stock Titan

Stock Titan - Jan 09, 2026

Fresenius Medical Care AG (ETR:FME) is favoured by institutional owners who hold 44% of the company - simplywall.st

simplywall.st - Jan 04, 2026

Fresenius Medical Care AG : Fresenius Medical Care AG is continuing its share buyback program in an accelerated manner - marketscreener.com

marketscreener.com - Jan 09, 2026

Fresenius Medical Care Annual General Meeting: Strong Performance Against Its Strategic Plan Results in Highest Dividend per Share in Its History - Fresenius Medical Care

Fresenius Medical Care - May 22, 2025

Fresenius Medical Care AG: Preliminary announcement of the publication of quarterly reports and quarterly/interim statements - TradingView — Track All Markets

TradingView — Track All Markets - Jan 09, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment